共 50 条
- [21] Laboratory data in healthy volunteers: reference values, reference changes, screening and laboratory adverse event limits in Phase I clinical trials European Journal of Clinical Pharmacology, 1999, 55 : 13 - 19
- [22] What if Institutional Review Boards (IRBs) treated healthy volunteers in clinical trials as their clients? AUSTRALASIAN MEDICAL JOURNAL, 2010, 3 (12): : 767 - 771
- [24] Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events European Journal of Clinical Pharmacology, 2008, 64 : 575 - 582
- [29] Characterization of renal biomarkers for use in clinical trials: biomarker evaluation in healthy volunteers DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 227 - 237
- [30] Healthy volunteer profile: Levels of anxiety, depression, socioeconomic aspects and candidates' motivations of participation in phase I clinical trials ANSIEDAD Y ESTRES-ANXIETY AND STRESS, 2020, 26 (2-3): : 83 - 90